Onconic Therapeutics Inc. (KOSDAQ:476060)
16,560
-480 (-2.82%)
At close: Feb 6, 2026
362.25% (1Y)
| Market Cap | 743.34B +277.2% |
| Revenue (ttm) | 46.65B +529.9% |
| Net Income | 16.75B |
| EPS | 1,513.84 |
| Shares Out | 44.89M |
| PE Ratio | 10.94 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 530,819 |
| Average Volume | 959,500 |
| Open | 16,400 |
| Previous Close | 17,040 |
| Day's Range | 15,920 - 16,790 |
| 52-Week Range | 3,138 - 26,600 |
| Beta | n/a |
| RSI | 36.26 |
| Earnings Date | Mar 13, 2026 |